Virica Biotech Receives Grant through Ontario Genomics’ BioCreate accelerator

Portfolio company Virica Biotech has been selected for the Ontario Genomics’s BioCreate accelerator program. Virica plays a critical role in the Canadian biotech ecosystem, announcing in May it is part of the Canadian Pandemic Preparedness Hub (CP2H), a multidisciplinary hub part of an investment by the Government of Canada to grow a strong and competitive biomanufacturing and life sciences sector.